Lister PD - Search Results

1

Mechanisms of β-lactam resistance among Pseudomonas aeruginosa.

Wolter DJ, Lister PD. Wolter DJ, et al. Among authors: lister pd. Curr Pharm Des. 2013;19(2):209-22. Curr Pharm Des. 2013. PMID: 22894618 Review.

2

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.

Wolter DJ, Black JA, Lister PD, Hanson ND. Wolter DJ, et al. Among authors: lister pd. J Antimicrob Chemother. 2009 Aug;64(2):294-300. doi: 10.1093/jac/dkp185. Epub 2009 May 25. J Antimicrob Chemother. 2009. PMID: 19468029

3

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Lister PD, Wolter DJ, Hanson ND. Lister PD, et al. Clin Microbiol Rev. 2009 Oct;22(4):582-610. doi: 10.1128/CMR.00040-09. Clin Microbiol Rev. 2009. PMID: 19822890 Free PMC article. Review.

4

Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.

Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD. Wolter DJ, et al. Among authors: lister pd. Diagn Microbiol Infect Dis. 2004 Sep;50(1):43-50. doi: 10.1016/j.diagmicrobio.2004.05.004. Diagn Microbiol Infect Dis. 2004. PMID: 15380277

5

Levofloxacin-imipenem combination prevents the emergence of resistance among clinical isolates of Pseudomonas aeruginosa.

Lister PD, Wolter DJ. Lister PD, et al. Clin Infect Dis. 2005 Feb 15;40 Suppl 2:S105-14. doi: 10.1086/426190. Clin Infect Dis. 2005. PMID: 15712098

6

AmpC and OprD are not involved in the mechanism of imipenem hypersusceptibility among Pseudomonas aeruginosa isolates overexpressing the mexCD-oprJ efflux pump.

Wolter DJ, Hanson ND, Lister PD. Wolter DJ, et al. Among authors: lister pd. Antimicrob Agents Chemother. 2005 Nov;49(11):4763-6. doi: 10.1128/AAC.49.11.4763-4766.2005. Antimicrob Agents Chemother. 2005. PMID: 16251325 Free PMC article.

7

Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.

Lister PD, Wolter DJ, Wickman PA, Reisbig MD. Lister PD, et al. J Antimicrob Chemother. 2006 May;57(5):999-1003. doi: 10.1093/jac/dkl063. Epub 2006 Mar 2. J Antimicrob Chemother. 2006. PMID: 16513915

8

Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin.

Wolter DJ, Schmidtke AJ, Hanson ND, Lister PD. Wolter DJ, et al. Among authors: lister pd. Antimicrob Agents Chemother. 2007 Aug;51(8):2997-3000. doi: 10.1128/AAC.00111-07. Epub 2007 May 21. Antimicrob Agents Chemother. 2007. PMID: 17517839 Free PMC article.

9

Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance.

Wolter DJ, Hanson ND, Lister PD. Wolter DJ, et al. Among authors: lister pd. FEMS Microbiol Lett. 2004 Jul 1;236(1):137-43. doi: 10.1016/j.femsle.2004.05.039. FEMS Microbiol Lett. 2004. PMID: 15212803

10

Chromosomally-encoded resistance mechanisms of Pseudomonas aeruginosa: therapeutic implications.

Lister PD. Lister PD. Am J Pharmacogenomics. 2002;2(4):235-43. doi: 10.2165/00129785-200202040-00003. Am J Pharmacogenomics. 2002. PMID: 12421094 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters